Drug Intermediate
Drug Iintermediate
Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].
References:
- [1]. Ma HC, et al. Homochiral Covalent Organic Framework for Catalytic Asymmetric Synthesis of a Drug Intermediate. J Am Chem Soc. 2020 Jul 22;142(29):12574-12578. [Content Brief]
- [2]. Ramachary D B, et al. Development of pharmaceutical drugs, drug intermediates and ingredients by using direct organo‐click reactions[J]. 2008.
All Product Categories
-
Drug Intermediate Related Products (4595)
Related Products (4595)
-
Ticagrelor impurity 12 (Standard)
0 ImagesCat. No.: HY-78540RCAS No.: 220241-61-2Ticagrelor impurity 12 (Standard) is the analytical standard of Ticagrelor impurity 12 (HY-78540). This product is intended for research and analytical applications.
-
Lamivudine impurity 3
0 ImagesCat. No.: HY-Z19686CAS No.: 1235712-40-9Lamivudine impurity 3 is an impurity of Lamivudine.
-
Fluphenazine decanoate impurity 11
0 ImagesCat. No.: HY-W715524CAS No.: 76005-65-7Fluphenazine decanoate impurity 11 is an impurity of Fluphenazine decanoate.
-
Atenolol impurity 2
0 ImagesCat. No.: HY-Z7840CAS No.: 1797116-92-7Synonyms: C-Desmethyl atenololAtenolol impurity 2 (C-Desmethyl atenolol) is an impurity of Atenolol.
-
4-Fluorobenzoic acid-13C,d4
0 ImagesCat. No.: HY-W013677S1CAS No.: 285977-82-44-Fluorobenzoic acid-13C,d4 is the 13C- and deuterium labeled 4-Fluorobenzoic acid (HY-W013677). 4-Fluorobenzoic acid is a drug intermediate that can be used to synthesize a series of hydrazone derivatives with antituberculosis activity and Schiff bases with DPPH radical scavenging activity.
-
Tenofovir impurity 25
0 ImagesCat. No.: HY-Z11920CAS No.: 1217630-57-3Tenofovir impurity 25 is an impurity of Tenofovir.
-
Levothyroxine impurity 12
0 ImagesCat. No.: HY-W701773CAS No.: 30804-52-5Levothyroxine impurity 12 is an impurity of Levothyroxine.
-
Budesonide impurity 87
0 ImagesCat. No.: HY-W741500CAS No.: 51372-28-2Budesonide impurity 87 is an impurity of Budesonide7.
-
Amlodipine impurity 7
0 ImagesCat. No.: HY-Z7879CAS No.: 318465-73-5Synonyms: 2-Carboxybenzoyl amlodipineAmlodipine impurity 7 (2-Carboxybenzoyl amlodipine) is an impurity of Amlodipine.
-
Escitalopram impurity 8
0 ImagesCat. No.: HY-W098648CAS No.: 488787-59-3Escitalopram impurity 8 is an impurity of Escitalopram.
-
Buspirone impurity 1
0 ImagesCat. No.: HY-W712558CAS No.: 2708578-34-9Buspirone impurity 1 is an impurity of Buspirone.
-
Quetiapine impurity 4
0 ImagesCat. No.: HY-Z8357CAS No.: 945668-94-0Synonyms: Quetiapine dimer impurityQuetiapine impurity 4 (Quetiapine dimer impurity) is an impurity of Quetiapine.
-
Apixaban impurity 39
0 ImagesCat. No.: HY-Z2652CAS No.: 1998079-14-3Apixaban impurity 39 is an impurity of Apixaban.
-
4-Phospho-D-erythronate
0 ImagesCat. No.: HY-111598CAS No.: 57229-25-14-Phospho-D-erythronate is a Ribose 5-phosphate isomerase inhibitor, intermediate in pyridoxal 5'-phosphate synthesis in some bacteria, and substrate for 4PE dehydrogenase (PdxB) in select proteobacteria.
-
Nicodil impurity 1
0 ImagesCat. No.: HY-W104177CAS No.: 40055-37-6Nicodil impurity 1 is an impurity of Nicodil.
-
Donepezil impurity 26
0 ImagesCat. No.: HY-W780602CAS No.: 896134-07-9Donepezil impurity 26 is an impurity of Donepezil.
-
4-Amino-2-hydroxybenzohydrazide
0 Images4-Amino-2-hydroxybenzohydrazide, an asymmetric unit, comprises two crystallographically independent molecules (A and B).
-
Sulfiram
0 ImagesSulfiram is a very weak aldehyde dehydrogenase (ALDH) inhibitor, with an IC50 value of 413 μM against Saccharomyces cerevisiae ALDH. As a photochemical precursor, Sulfiram undergoes photoconversion to form Disulfiram (HY-B0240), a potent ALDH inhibitor. Sulfiram inhibits the dimerization of the extracellular domain fragment (amino acid residues 230-624) of amyloid precursor protein (APP), alters the monomer-dimer equilibrium, induces conformational changes in the fragment, and enhances the production of sAPPα via α-cleavage of APP. Sulfiram can be used in research related to scabies and Alzheimer's disease.
